Recombinant human nerve growth factor April 13, 2017 Recombinant human nerve growth factor Trade Name OXERVATE Orphan Indication Neurotrophic keratitis EU Market Approval EU EU Designation Date 2015-12-14 00:00:00 Sponsor Dompé farmaceutici S.p.A.
